Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Roivant Sciences will partner with Ligand Pharmaceuticals to codevelop its type 2 diabetes candidate LGD-6972 through a collaboration that could generate up to $533.8 million for Ligand—and is aimed ...
1 Day 6972 0.00% DJIA 0.55% Russell 2K 0.93% Retail/Wholesale 2.87% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results